Forget the arguments over fit and fat in the development of diabetes and the resulting complications. Both fitness and fatness can be addressed by the same prescription: physical activity.
Forget the arguments over fit and fat in the development of diabetes and the resulting complications. Both fitness and fatness can be addressed by the same prescription: physical activity.
"Exercise is pleiotropic," according to Timothy Church, MD, PhD, Pennington Biomedical Research Center, Baton Rouge, LA. "Exercise benefits nearly every cell in the human body. Don?t talk ?fit? to your patients, don?t talk ?fat.? Just get them moving!"
Fit and fat both play important roles in the development of diabetes and its complications, Dr. Church said. Excess weight is a significant risk factor for developing diabetes and cardiovascular disease.
"Study after study shows that the fatter you are, the greater your risk," he said. "But if you are talking about dying from cardiovascular disease, fitness is more important."
Physical activity is key, Dr. Church continued. As little as 10 minutes of walking daily can increase cardiovascular fitness and aid weight loss. More exercise is better. Thirty minutes a day, five days a week, is a reasonable target.
"The relationship between activity and benefit is curvilinear," he said. "The greatest relative benefit comes to people at the couch potato end of the activity spectrum. If we could just get people off the couch just a little bit, we could benefit them tremendously."
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More